IL89222A - Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins - Google Patents
Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteinsInfo
- Publication number
- IL89222A IL89222A IL8922289A IL8922289A IL89222A IL 89222 A IL89222 A IL 89222A IL 8922289 A IL8922289 A IL 8922289A IL 8922289 A IL8922289 A IL 8922289A IL 89222 A IL89222 A IL 89222A
- Authority
- IL
- Israel
- Prior art keywords
- group
- protein
- groups
- radionuclide
- proteinaceous material
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8800302 | 1988-02-09 | ||
NL8801728 | 1988-07-08 | ||
NL8802408 | 1988-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL89222A0 IL89222A0 (en) | 1989-09-10 |
IL89222A true IL89222A (en) | 1995-03-30 |
Family
ID=27352196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8922289A IL89222A (en) | 1988-02-09 | 1989-02-08 | Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0401302B1 (de) |
AT (1) | ATE124269T1 (de) |
AU (2) | AU635204B2 (de) |
DE (1) | DE68923274T2 (de) |
FI (1) | FI903917A0 (de) |
IL (1) | IL89222A (de) |
WO (1) | WO1989007456A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910700242A (ko) * | 1988-12-22 | 1991-03-14 | 마틴 골드스타인 | 간섭 결합제 및 그 방법 |
FR2650749B1 (fr) * | 1989-08-08 | 1994-09-02 | Univ Rouen | Methode de diagnostic et/ou de traitement, notamment du cancer |
WO1991002547A1 (en) * | 1989-08-24 | 1991-03-07 | Australian Nuclear Science & Technology Organisation | Radio-labelled antibodies for imaging |
WO1991007991A1 (en) * | 1989-11-30 | 1991-06-13 | Mallinckrodt Medical, Inc. | Method for preparing a metal-radionuclide-labelled protein |
EP0485664A1 (de) * | 1990-11-13 | 1992-05-20 | Mallinckrodt Diagnostica (Holland) B.V. | Verfahren zur Herstellung von einem diagnostischen Mittel zur Feststellung von Entzündungen |
EP0498333B1 (de) * | 1991-02-05 | 1997-01-15 | Cis Bio International | Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz |
US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
US5997844A (en) * | 1991-02-08 | 1999-12-07 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
US7238340B1 (en) | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
ATE186550T1 (de) * | 1991-04-22 | 1999-11-15 | Mallinckrodt Medical Inc | Verbindungen und pharmazeutische zusammensetzungen zum nachweis und zur lokalisierung von geweben mit neurokinin-1- rezeptoren |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5403573A (en) * | 1992-04-23 | 1995-04-04 | The Curators Of The University Of Missouri | Radiolabeled protein composition and method for radiation synovectomy |
US5508020A (en) * | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
WO1994025488A1 (en) * | 1993-05-03 | 1994-11-10 | Mallinckrodt Medical, Inc. | Method for preparing a metal-radionuclide-labelled protein |
AU7261994A (en) * | 1993-07-19 | 1995-02-20 | Resolution Pharmaceuticals Inc. | Hydrazino-type radionuclide chelators having an n3s configuration |
US5858327A (en) * | 1993-09-03 | 1999-01-12 | Resolutions Pharmaceuticals, Inc. | Hydrazino-type N2 S2 radionuclide chelating compounds |
US5574140A (en) * | 1993-09-03 | 1996-11-12 | Resolution Pharmaceutical Inc. | Hydrazino-type N2 S2 chelators |
DE19505960A1 (de) * | 1995-02-21 | 1996-08-22 | Deutsches Krebsforsch | Konjugat zur individuellen Dosierung von Arzneimitteln |
US6043256A (en) * | 1996-09-16 | 2000-03-28 | Grassetti; Davide R. | Antimutagenic agents |
KR100367125B1 (ko) * | 1996-12-02 | 2003-08-27 | 그라코 인크. | 패턴제어식분배장치 |
EP2380596A1 (de) | 2010-04-20 | 2011-10-26 | Technische Universität München | Cyclopentapeptid-Derivate und deren Verwendungen |
EP2380597A1 (de) | 2010-04-20 | 2011-10-26 | Technische Universität München | Cyclopeptid-Derivate und deren Verwendungen |
AU2014396468B2 (en) | 2014-06-06 | 2019-02-21 | Technische Universitat Munchen | Modified cyclopentapeptides and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3223585A (en) * | 1965-02-23 | 1965-12-14 | American Cyanamid Co | Pesticidal monosulfur heterocyclic compositions |
JPS5835520B2 (ja) * | 1976-06-01 | 1983-08-03 | 株式会社第一ラジオアイソト−プ研究所 | 6−カルボキシメチルチオコルチゾ−ルおよびその誘導体 |
US4479930A (en) * | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
US4652519A (en) * | 1983-02-03 | 1987-03-24 | Yeda Research And Development Company Limited | Bifunctional chelating agents and process for their production |
ATE66469T1 (de) * | 1985-01-14 | 1991-09-15 | Neorx Corp | Metall-radionuklid markiertes protein fuer diagnose und therapie. |
US4678667A (en) * | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
US4877868A (en) * | 1986-03-12 | 1989-10-31 | Neorx Corporation | Radionuclide antibody coupling |
-
1989
- 1989-02-08 EP EP89904426A patent/EP0401302B1/de not_active Expired - Lifetime
- 1989-02-08 DE DE68923274T patent/DE68923274T2/de not_active Expired - Fee Related
- 1989-02-08 AU AU33686/89A patent/AU635204B2/en not_active Ceased
- 1989-02-08 WO PCT/US1989/000500 patent/WO1989007456A1/en active IP Right Grant
- 1989-02-08 AT AT89904426T patent/ATE124269T1/de not_active IP Right Cessation
- 1989-02-08 IL IL8922289A patent/IL89222A/en not_active IP Right Cessation
-
1990
- 1990-08-08 FI FI903917A patent/FI903917A0/fi not_active Application Discontinuation
-
1993
- 1993-01-06 AU AU31056/93A patent/AU658959B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU635204B2 (en) | 1993-03-18 |
WO1989007456A1 (en) | 1989-08-24 |
EP0401302A4 (de) | 1994-03-30 |
AU3105693A (en) | 1993-02-25 |
AU3368689A (en) | 1989-09-06 |
ATE124269T1 (de) | 1995-07-15 |
IL89222A0 (en) | 1989-09-10 |
FI903917A0 (fi) | 1990-08-08 |
EP0401302A1 (de) | 1990-12-12 |
DE68923274T2 (de) | 1995-11-09 |
AU658959B2 (en) | 1995-05-04 |
DE68923274D1 (de) | 1995-08-03 |
EP0401302B1 (de) | 1995-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0401302B1 (de) | Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins | |
US5202451A (en) | Anchimeric radiometal chelating compounds | |
US4897255A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US5175343A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US5162505A (en) | Proteins modified with positively charged carriers and compositions prepared therefrom | |
KR100235137B1 (ko) | 모노아민, 다아민, 티올-함유 금속 킬레이트제 | |
EP0188256B1 (de) | Metall-Radionuklid markiertes Protein für Diagnose und Therapie | |
US5037630A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US5242679A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
KR100235136B1 (ko) | 영상화용 테크네튬-99m 표지화 펩티드 | |
US5095111A (en) | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products | |
EP0510132A1 (de) | Polymere träger zur freisetzung kovalent gebundener wirkstoffe. | |
EP0404605B1 (de) | Tri-aza-Makrocyclen und Verfahren zu ihrer Herstellung | |
KR100330794B1 (ko) | 혈관질병진단제 | |
EP0420934B1 (de) | Bifunktionelle kuppler und daraus hergestellte mit radionukleid markierte zusammensetzungen | |
EP0345723B1 (de) | Diäthylentriaminpentaessigsäure-Derivate | |
CA2165537A1 (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
WO1994005627A1 (en) | Hydroxamic acid-based bifunctional chelating compounds | |
US5120526A (en) | Method of producing metal radionuclide labeled proteins for diagnosis and therapy | |
US5196515A (en) | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products | |
CA2129033A1 (en) | Radiolabelled peptide compounds | |
US5395946A (en) | Bifunctional chelating agents | |
US6696551B1 (en) | 225Ac-HEHA and related compounds, methods of synthesis and methods of use | |
WO2000059896A1 (en) | 225Ac-HEHA AND RELATED COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE | |
EP0654043A1 (de) | Herstellungsmethode eines metallradionuklid markierten proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |